TCR2 Therapeutics Inc. (TCRR) Declined -5.49% or -0.89 To Price $15.33 On Thursday


TCR2 Therapeutics Inc. (TCRR) declined -5.49% or -0.89 to $15.33. It is near to 16339 shares traded, which is 76.48% compare to the average total volume 21363. The market cap of TCRR is $367.00 million. The year to date change is 2.14%. The 52 week price range is from $13.31 to $25.47. Price of TCRR have changed 4.74% during last week. It have changed 5.90% over last month, -1.27% over last 3 months, 8.43% over last 6 months and 8.43% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for TCRR is 16.17. It is 5.48% above current price. The 52-week High is 25.47. It is 66.14% from the current price. The 52-week Low is 13.31. It is -13.18% from current price.

There are some statistics of TCRR. It is has market cap $367.00 million. The share outstanding is 23.94 million. The average volume is 21363. The percent of top 15 Institution holding is 4.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of TCRR is -55.47%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of TCRR is -53.84%.


Tags:

Share this post